IP Library Granted Patent US 12,354,745
Granted Patent B2
US 12,354,745 · App. 18/067,417 · Granted Jul 8, 2025

Prediction based delivering or guiding of therapy for diabetes

Inventors: Patrick E. Weydt (Moorpark, CA); Pratik J. Agrawal (Porter Ranch, CA); Louis J. Lintereur (Boise, ID); Lavie Golenberg (Bloomfield Hills, MI); David Dunleavy (West Hills, CA)
Assignee: MEDTRONIC MINIMED, INC.
G16H40/67A61B5/14532A61B5/7405A61B5/746A61K38/28A61M5/14244A61M5/14248A61M5/1723G06F3/017G06N3/08G16H20/17G16H20/60G16H40/20G16H70/40H04W4/027A61M2205/3584A61M2205/502A61M2205/505A61M2205/52A61M2205/581A61M2205/582A61M2205/583A61M2205/8206A61M2230/201A61M2230/63H04M1/72454H04M1/72463
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,354,745
App. No.
18/067,417
Granted
Jul 8, 2025
Kind
B2
Abstract

An example system for therapy delivery includes one or more processors configured to in response to a prediction indicating that the meal event is to occur, output instructions to an insulin delivery device to deliver a partial therapy dosage, to a device to notify the patient to use the insulin delivery device to take the partial therapy dosage, or to the insulin delivery device to prepare the partial therapy dosage prior to the meal event occurring, and in response to a determination indicating that the meal event is occurring (e.g., based on movement characteristics of a patient arm), output instructions to the insulin delivery device to deliver a remaining therapy dosage, to the device to notify the patient to use the insulin delivery device to take the remaining therapy dosage, or to the insulin delivery device to prepare the remaining therapy dosage.

Claims (52)

1. A system for therapy delivery, the system comprising:

one or more processors configured to:

predict that a meal event is to occur;

determine an amount of insulin to deliver to a patient to accommodate consumption of a meal;

in response to the prediction indicating that the meal event is to occur, output instructions to at least one of: (1) an insulin delivery device to cause the insulin delivery device to deliver a partial therapy dosage prior to the meal event occurring, (2) a device to notify the patient to use the insulin delivery device to take the partial therapy dosage prior to the meal event occurring, or (3) the insulin delivery device to cause the insulin delivery device to prepare the partial therapy dosage prior to the meal event occurring, wherein the partial therapy dosage comprises a portion of the determined amount of insulin that is to be delivered to the patient to accommodate consumption of the meal;

determine that the meal event is occurring based on one or more movement characteristics of movement of an arm of the patient; and

in response to the determination indicating that the meal event is occurring, output instructions to at least one of: (1) the insulin delivery device to deliver a remaining therapy dosage, (2) the device to notify the patient to use the insulin delivery device to take the remaining therapy dosage, or (3) the insulin delivery device to cause the insulin delivery device to prepare the remaining therapy dosage, wherein the remaining therapy dosage comprises a remaining portion of the determined amount of insulin that is to be delivered to the patient to accommodate consumption of the meal.

2. The system of claim 1 ,

wherein the one or more processors comprises a first set of one or more processors on one or more servers and a second set of one or more processors on a wearable device worn by the patient,

wherein to predict that a meal event is to occur, the first set of one or more processors is configured to:

receive one or more contextual information of the patient; and

determine that the meal event is to occur based on the received contextual information,

wherein to determine that the meal event is occurring, at least one of the first set of processors or the second set of processors is configured to determine that the meal event is occurring based on the one or more movement characteristics.

3. The system of claim 1 , wherein the partial therapy dosage is less than the remaining therapy dosage.

4. The system of claim 1 , wherein the instruction to the insulin delivery device to cause the insulin delivery device to deliver the partial therapy dosage comprises an instruction to the insulin delivery device to reduce a patient glucose target to cause the insulin delivery device to deliver the partial therapy dosage.

5. The system of claim 1 , wherein the partial therapy dosage comprises a preselected therapy dosage, and wherein the one or more processors are configured to determine the remaining therapy dosage based on one or more of a glucose level measurement or an amount of carbohydrates predicted to be consumed by the patient.

6. The system of claim 1 , further comprising a patient device, wherein at least one of the one or more processors is a processor of the patient device.

7. The system of claim 1 , wherein to predict that the meal event is to occur, the one or more processors are configured to receive one or more contextual information of the patient, wherein the one or more processors are configured to determine an amount of partial therapy dosage based on a number of contextual information that is received.

8. The system of claim 1 , further comprising the insulin delivery device, wherein the insulin delivery device comprises at least one of an insulin pump or an injection device.

9. The system of claim 1 , further comprising:

a glucose sensor,

wherein the one or more processors are configured to, in response to the determination that the meal event is occurring, instruct the glucose sensor to output a glucose level of the patient at a first rate that is higher than a second rate at which the glucose sensor outputs the glucose level of the patient when the meal event is not occurring.

10. The system of claim 1 , wherein the one or more processors are configured to:

determine an amount of carbohydrates the patient is to eat during the meal event and a number of bites the patient will take during the meal event; and

based on the determination of the amount of carbohydrates the patient is to eat and the number of bites the patient will take, output instructions to cause the insulin delivery device to deliver a micro-bolus or a series of micro-boluses of insulin therapy during the meal event.

11. The system of claim 10 , wherein to output the instructions to cause the insulin delivery device to deliver the series of micro-boluses, the one or more processors are configured to output instructions to cause the insulin delivery device to deliver the series of micro-boluses with every detected bite or in regular intervals of time.

12. A method comprising:

predicting, with one or more processors, that a meal event is to occur;

determining, with the one or more processors, an amount of insulin to deliver to a patient to accommodate consumption of a meal;

in response to the prediction indicating that the meal event is to occur, outputting, with the one or more processors, instructions to at least one of: (1) an insulin delivery device to cause the insulin delivery device to deliver a partial therapy dosage prior to the meal event occurring, (2) a device to notify the patient to use the insulin delivery device to take the partial therapy dosage prior to the meal event occurring, or (3) the insulin delivery device to cause the insulin delivery device to prepare the partial therapy dosage prior to the meal event occurring, wherein the partial therapy dosage comprises a portion of the determined amount of insulin that is to be delivered to the patient to accommodate consumption of the meal;

determining, with the one or more processors, that the meal event is occurring based on one or more movement characteristics of movement of an arm of the patient; and

in response to the determination indicating that the meal event is occurring, outputting, with the one or more processors, instructions to at least one of: (1) the insulin delivery device to deliver a remaining therapy dosage, (2) the device to notify the patient to use the insulin delivery device to take the remaining therapy dosage, or (3) the insulin delivery device to cause the insulin delivery device to prepare the remaining therapy dosage, wherein the remaining therapy dosage comprises a remaining portion of the determined amount of insulin that is to be delivered to the patient to accommodate consumption of the meal.

13. The method of claim 12 ,

wherein the one or more processors comprises a first set of one or more processors on one or more servers and a second set of one or more processors on a wearable device worn by the patient,

wherein predicting that a meal event is to occur comprises:

receiving, with the first set of one or more processors, one or more contextual information of the patient; and

determining, with the first set of one or more processors, that the meal event is to occur based on the received contextual information,

wherein determining that the meal event is occurring comprises determining, with at least one of the first set of one or more processors or the second set of one or more processors, that the meal event is occurring based on the one or more movement characteristics.

14. The method of claim 12 , wherein the partial therapy dosage is less than the remaining therapy dosage.

15. The method of claim 12 , wherein the instruction to the insulin delivery device to cause the insulin delivery device to deliver the partial therapy dosage comprises an instruction to the insulin delivery device to reduce a patient glucose target to cause the insulin delivery device to deliver the partial therapy dosage.

16. The method of claim 12 , wherein the partial therapy dosage comprises a preselected therapy dosage, the method further comprising determining, with the one or more processors, the remaining therapy dosage based on one or more of a glucose level measurement or an amount of carbohydrates predicted to be consumed by the patient.

17. The method of claim 12 , wherein predicting that the meal event is to occur comprises receiving one or more contextual information of the patient, the method further comprising determining an amount of partial therapy dosage based on a number of contextual information that is received.

18. The method of claim 12 , further comprising:

determining an amount of carbohydrates the patient is to eat during the meal event and a number of bites the patient will take during the meal event; and

based on the determination of the amount of carbohydrates the patient is to eat and the number of bites the patient will take, outputting instructions to cause the insulin delivery device to deliver a micro-bolus or a series of micro-boluses of insulin therapy during the meal event.

19. The method of claim 18 , wherein outputting the instructions to cause the insulin delivery device to deliver the series of micro-boluses comprises outputting instructions to cause the insulin delivery device to deliver the series of micro-boluses with every detected bite or in regular intervals of time.

20. A computer-readable storage medium storing instructions thereon that when executed cause one or more processors to:

predict that a meal event is to occur;

determine an amount of insulin to deliver to a patient to accommodate consumption of a meal;

in response to the prediction indicating that the meal event is to occur, output instructions to at least one of: (1) an insulin delivery device to cause the insulin delivery device to deliver a partial therapy dosage prior to the meal event occurring, (2) a device to notify the patient to use the insulin delivery device to take the partial therapy dosage prior to the meal event occurring, or (3) the insulin delivery device to cause the insulin delivery device to prepare the partial therapy dosage prior to the meal event occurring, wherein the partial therapy dosage comprises a portion of the determined amount of insulin that is to be delivered to the patient to accommodate consumption of the meal;

determine that the meal event is occurring based on one or more movement characteristics of movement of an arm of the patient; and

in response to the determination indicating that the meal event is occurring, output instructions to at least one of: (1) the insulin delivery device to deliver a remaining therapy dosage, (2) the device to notify the patient to use the insulin delivery device to take the remaining therapy dosage, or (3) the insulin delivery device to cause the insulin delivery device to prepare the remaining therapy dosage, wherein the remaining therapy dosage comprises a remaining portion of the determined amount of insulin that is to be delivered to the patient to accommodate consumption of the meal.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2022
From: WEYDT, PATRICK E.; AGRAWAL, PRATIK J.; LINTEREUR, LOUIS J.; GOLENBERG, LAVIE; DUNLEAVY, DAVID
To: MEDTRONIC MINIMED, INC.
Reel/Frame 062129/0630 →
Continuity (4)
Continuation 17004951 · Aug 27, 2020
Provisional Application 62893717 · Aug 29, 2019
Provisional Application 62893722 · Aug 29, 2019
Related Publication 20230121873A1 · Apr 20, 2023
References Cited (66)
US 7935076B2 · Estes et al. · 2011 [cited by applicant]
US 9008803B2 · Blomquist · 2015 [cited by applicant]
US 9037125B1 · Kadous · 2015 [cited by applicant]
US 10080840B2 · Gescheit et al. · 2018 [cited by applicant]
US 10258745B2 · Despa et al. · 2019 [cited by applicant]
US 10307538B2 · Desborough et al. · 2019 [cited by applicant]
US 11551812B2 · Weydt · 2023 [cited by examiner]
US 11710562B2 · Weydt et al. · 2023 [cited by applicant]
US 11990236B2 · Weydt et al. · 2024 [cited by applicant]
US 20130217990A1 · Saettel et al. · 2013 [cited by applicant]
US 20140012510A1 · Mensinger et al. · 2014 [cited by applicant]
US 20140184772A1 · Hanina et al. · 2014 [cited by applicant]
US 20140315162A1 · Ehrenkranz · 2014 [cited by applicant]
US 20150246179A1 · Zur et al. · 2015 [cited by applicant]
US 20160306932A1 · Fateh et al. · 2016 [cited by applicant]
US 20170053552A1 · Zhong et al. · 2017 [cited by applicant]
US 20170150360A1 · Caldwell et al. · 2017 [cited by applicant]
US 20170189625A1 · Cirillo et al. · 2017 [cited by applicant]
US 20170203030A1 · Brewer et al. · 2017 [cited by applicant]
US 20170203039A1 · Desborough et al. · 2017 [cited by applicant]
US 20170228518A1 · Booth et al. · 2017 [cited by applicant]
US 20170249445A1 · Devries et al. · 2017 [cited by applicant]
US 20170257844A1 · Miller et al. · 2017 [cited by applicant]
US 20170311903A1 · Davis et al. · 2017 [cited by applicant]
US 20170332347A1 · Boss et al. · 2017 [cited by applicant]
US 20180109412A1 · Xuan et al. · 2018 [cited by applicant]
US 20180147362A1 · Arenas Latorre et al. · 2018 [cited by applicant]
US 20180214077A1 · Dunki-Jacobs et al. · 2018 [cited by applicant]
US 20180271418A1 · Hayter et al. · 2018 [cited by applicant]
US 20190052748A1 · Stewart · 2019 [cited by applicant]
US 20190158447A1 · Aggarwal et al. · 2019 [cited by applicant]
US 20190182749A1 · Breaux et al. · 2019 [cited by applicant]
US 20190236465A1 · Vleugels · 2019 [cited by applicant]
US 20190246914A1 · Canstantin et al. · 2019 [cited by applicant]
US 20190252079A1 · Constantin et al. · 2019 [cited by applicant]
US 20190274624A1 · Mazlish et al. · 2019 [cited by applicant]
US 20190382025A1 · Mena Benito et al. · 2019 [cited by applicant]
US 20200129099A1 · Mi et al. · 2020 [cited by applicant]
US 20200135320A1 · Vleugels · 2020 [cited by applicant]
US 20200152312A1 · Connor · 2020 [cited by applicant]
US 20210060247A1 · Weydt et al. · 2021 [cited by applicant]
US 20210065894A1 · Weydt et al. · 2021 [cited by applicant]
US 20230317277A1 · Weydt et al. · 2023 [cited by applicant]
US 20240257965A1 · Weydt et al. · 2024 [cited by applicant]
CN 109789264A · 2019 [cited by applicant]
EP 3417773A1 · 2018 [cited by applicant]
KR 20180028823A · 2018 [cited by applicant]
WO 2014115025A1 · 2014 [cited by applicant]
WO 2017027258A1 · 2017 [cited by applicant]
Castle et el., “Future of Automated Insulin Delivery Systems,” Diabetes Technology & Therapeutics, vol. 19, Supplement 3, Jun. 1, 2017, 6 pp. [cited by applicant]
Gomez-Peralta et al., “A Novel Insulin Delivery Optimization and Tracking System,” Diabetes Technology & Therapeutics, vol. 21, No. 4, Apr. 4, 2019, 6 pp. [cited by applicant]
International Preliminary Report on Patentability from International Application No. PCT/US2020/048446, dated Mar. 10, 2022, 9 pp. [cited by applicant]
International Search Report and Written Opinion of International Application No. PCT/US2020/048446, mailed Nov. 20, 2020, 15 pp. [cited by applicant]
Notice of Allowance from U.S. Appl. No. 17/004,951 dated Sep. 15, 2022, 8 pp. [cited by applicant]
Communication pursuant to Rules 161(1) and 162 EPC from counterpart European Application No. 20771398.3 dated Apr. 5, 2022, 3 pp. [cited by applicant]
Response to Communication pursuant to Rules 161(1) and 162 EPC dated Apr. 5, 2022, from counterpart European Application No. 20771398.3, filed Aug. 10, 2022, 15 pp. [cited by applicant]
CN Office Action dated Nov. 29, 2024 in CN Application No. 202080059875.2, with English translation [MEDTP121]. [cited by applicant]
EP Office Action dated Aug. 9, 2024, in EP Application No. 20771398.3 [MEDTP109]. [cited by applicant]
International Preliminary Report on Patentability dated Mar. 10, 2022 in PCT Application No. PCT/US2020/048461. [cited by applicant]
International Search Report and Written Opinion dated Nov. 6, 2020 in PCT Application No. PCT/US2020/048461. [cited by applicant]
Shivers J., et al., “Turn It Off: Diabetes Device Alarm Fatigue Considerations for the Present and the Future,” Journal of Diabetes Science and Technology, May 2013, vol. 7 (3), pp. 789-794. [cited by applicant]
U.S. Advisory Action dated Dec. 13, 2023 in U.S. Appl. No. 17/004,981 [MEDTP120US]. [cited by applicant]
U.S. Final Office Action dated Oct. 27, 2023 in U.S. Appl. No. 17/004,981 [MEDTP120US]. [cited by applicant]
U.S. Non-Final Office Action dated Jul. 6, 2023, in U.S. Appl. No. 17/004,981 [MEDTP120US]. [cited by applicant]
U.S. Notice of Allowance dated Jan. 23, 2024 in U.S. Appl. No. 17/004,981 [MEDTP120US]. [cited by applicant]
U.S. Office Action dated Sep. 15, 2022, in U.S. Appl. No. 17/004,951 [A0002725US03]. [cited by applicant]